Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Protara Therapeutics will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. Management will discuss the company's clinical-stage pipeline, including the lead candidate TARA-002 and IV Choline Chloride.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.